Raju Prasad, Chief Financial Officer at CRISPR Therapeutics AG (CRSP), sold 19,000 shares at $55.10 ($1.1M) on 2025-12-22, disclosed to the SEC on 2025-12-23.
Scheduled sale ($1.1M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.10 | 3,528 | $194K | 18.3% |
| 2 | $55.10 | 3,528 | $194K | 18.3% |
| 3 | $56.33 | 5,472 | $308K | 29.0% |
| 4 | $56.33 | 5,472 | $308K | 29.0% |
| 5 | $56.89 | 1,000 | $57K | 5.4% |
| Total | $55.90 avg | 19,000 |
| $1.1M |
| 100% |
| Filing → |
| CRSP | SELL | 2026-01-26 | $2.1M | — | Filing → |
| CRSP | SELL | 2026-01-08 | $3.3M | — | Filing → |
| CRSP | SELL | 2025-03-24 | $181K | — | Filing → |